According to Cognitive Market Research, the global STD Diagnostic market size will be USD 10258.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 4103.40 million in 2024 and will rise at the compound annual growth rate (CAGR) of 6.2% from the year 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 3077.55 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 2359.46 million in 2024 and will rise at the compound annual growth rate (CAGR) of 10.0% from the year 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 512.93 million in 2024 and will rise at a compound annual growth rate (CAGR) of 7.4% from th year 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 205.17 million in 2024 and will rise at the compound annual growth rate (CAGR) of 7.7% from the year 2024 to 2031.
The molecular diagnostics category is the fastest growing segment of the STD Diagnostic industry
